Trial · NCT03252249
Results by group54
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 40 of 54
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time-to-event: Cardiovascular Death and Non-fatal Myocardial Infarction | 3 Months Dual Anti-platelet Therapy | 422.876 | Standard Error 2.1559 | days | |
| Time-to-event: Cardiovascular Death and Non-fatal Myocardial Infarction | 12 Months Dual Anti-platelet Therapy | 424.670 | Standard Error 2.1010 | days | |
| Incidence: Cardiovascular Death and Non-fatal Myocardial Infarction | 3 Months Dual Anti-platelet Therapy | 236 | Participants | ||
| Incidence: Cardiovascular Death and Non-fatal Myocardial Infarction | 12 Months Dual Anti-platelet Therapy | 226 | Participants | ||
| Time-to-event: Cardiovascular Mortality (Cardiac and Non-cardiac) | 3 Months Dual Anti-platelet Therapy | 449.943 | Standard Error 0.8891 | days | |
| Time-to-event: Cardiovascular Mortality (Cardiac and Non-cardiac) | 12 Months Dual Anti-platelet Therapy | 447.897 | Standard Error 1.0372 | days | |
| Incidence: Cardiovascular Mortality (Cardiac and Non-cardiac) | 3 Months Dual Anti-platelet Therapy | 40 | Participants | ||
| Incidence: Cardiovascular Mortality (Cardiac and Non-cardiac) | 12 Months Dual Anti-platelet Therapy | 56 | Participants | ||
| Time-to-event: Myocardial Infarction (Fatal and Non-fatal) | 3 Months Dual Anti-platelet Therapy | 424.471 | Standard Error 2.1157 | days | |
| Time-to-event: Myocardial Infarction (Fatal and Non-fatal) | 12 Months Dual Anti-platelet Therapy | 427.444 | Standard Error 2.0181 | days | |
| Incidence: Myocardial Infarction (Fatal and Non-fatal) | 3 Months Dual Anti-platelet Therapy | 221 | Participants | ||
| Incidence: Myocardial Infarction (Fatal and Non-fatal) | 12 Months Dual Anti-platelet Therapy | 203 | Participants | ||
| Incidence: Intracranial Haemorrhage | 3 Months Dual Anti-platelet Therapy | 0 | Participants | ||
| Incidence: Intracranial Haemorrhage | 12 Months Dual Anti-platelet Therapy | 10 | Participants | ||
| Time-to-event: Coronary Revascularisation | 3 Months Dual Anti-platelet Therapy | 414.488 | Standard Error 2.3733 | days | |
| Time-to-event: Coronary Revascularisation | 12 Months Dual Anti-platelet Therapy | 417.081 | Standard Error 2.3383 | days | |
| Incidence: Coronary Revascularisation | 3 Months Dual Anti-platelet Therapy | 286 | Participants | ||
| Incidence: Coronary Revascularisation | 12 Months Dual Anti-platelet Therapy | 259 | Participants | ||
| Time-to-event: Stent Thrombosis | 3 Months Dual Anti-platelet Therapy | 450.566 | Standard Error 0.8329 | days | |
| Time-to-event: Stent Thrombosis | 12 Months Dual Anti-platelet Therapy | 450.026 | Standard Error 0.9228 | days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03252249/results?page=2